| pubmed-article:16781230 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16781230 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:16781230 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
| pubmed-article:16781230 | lifeskim:mentions | umls-concept:C0034656 | lld:lifeskim |
| pubmed-article:16781230 | lifeskim:mentions | umls-concept:C1522318 | lld:lifeskim |
| pubmed-article:16781230 | lifeskim:mentions | umls-concept:C0178602 | lld:lifeskim |
| pubmed-article:16781230 | lifeskim:mentions | umls-concept:C1948041 | lld:lifeskim |
| pubmed-article:16781230 | lifeskim:mentions | umls-concept:C0288672 | lld:lifeskim |
| pubmed-article:16781230 | lifeskim:mentions | umls-concept:C0070166 | lld:lifeskim |
| pubmed-article:16781230 | lifeskim:mentions | umls-concept:C0333186 | lld:lifeskim |
| pubmed-article:16781230 | lifeskim:mentions | umls-concept:C0522523 | lld:lifeskim |
| pubmed-article:16781230 | lifeskim:mentions | umls-concept:C0522776 | lld:lifeskim |
| pubmed-article:16781230 | lifeskim:mentions | umls-concept:C0936012 | lld:lifeskim |
| pubmed-article:16781230 | lifeskim:mentions | umls-concept:C1550147 | lld:lifeskim |
| pubmed-article:16781230 | lifeskim:mentions | umls-concept:C0687568 | lld:lifeskim |
| pubmed-article:16781230 | lifeskim:mentions | umls-concept:C1708715 | lld:lifeskim |
| pubmed-article:16781230 | lifeskim:mentions | umls-concept:C2346689 | lld:lifeskim |
| pubmed-article:16781230 | lifeskim:mentions | umls-concept:C0439608 | lld:lifeskim |
| pubmed-article:16781230 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:16781230 | pubmed:dateCreated | 2006-6-19 | lld:pubmed |
| pubmed-article:16781230 | pubmed:abstractText | ISAR-REACT was a trial designed to evaluate whether the glycoprotein IIb/IIIa inhibitor abciximab is beneficial in patients undergoing elective percutaneous coronary intervention (PCI) with stent placement after pretreatment with a 600 mg loading dose of clopidogrel. Objective for the angiographic substudy was to determine the impact of abciximab on angiographic restenosis after coronary stent placement. Previous analyses have suggested a reduction in the incidence of restenosis after the administration of abciximab. | lld:pubmed |
| pubmed-article:16781230 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16781230 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16781230 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:16781230 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16781230 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16781230 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16781230 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16781230 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16781230 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16781230 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16781230 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16781230 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:16781230 | pubmed:issn | 1097-6744 | lld:pubmed |
| pubmed-article:16781230 | pubmed:author | pubmed-author:KastratiAdnan... | lld:pubmed |
| pubmed-article:16781230 | pubmed:author | pubmed-author:MehilliJulind... | lld:pubmed |
| pubmed-article:16781230 | pubmed:author | pubmed-author:DirschingerJo... | lld:pubmed |
| pubmed-article:16781230 | pubmed:author | pubmed-author:SchömigAlbert... | lld:pubmed |
| pubmed-article:16781230 | pubmed:author | pubmed-author:HausleiterJör... | lld:pubmed |
| pubmed-article:16781230 | pubmed:author | pubmed-author:DotzerFranzF | lld:pubmed |
| pubmed-article:16781230 | pubmed:author | pubmed-author:SchühlenHelmu... | lld:pubmed |
| pubmed-article:16781230 | pubmed:author | pubmed-author:BollweinHilde... | lld:pubmed |
| pubmed-article:16781230 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:16781230 | pubmed:volume | 151 | lld:pubmed |
| pubmed-article:16781230 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16781230 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16781230 | pubmed:pagination | 1248-54 | lld:pubmed |
| pubmed-article:16781230 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
| pubmed-article:16781230 | pubmed:meshHeading | pubmed-meshheading:16781230... | lld:pubmed |
| pubmed-article:16781230 | pubmed:meshHeading | pubmed-meshheading:16781230... | lld:pubmed |
| pubmed-article:16781230 | pubmed:meshHeading | pubmed-meshheading:16781230... | lld:pubmed |
| pubmed-article:16781230 | pubmed:meshHeading | pubmed-meshheading:16781230... | lld:pubmed |
| pubmed-article:16781230 | pubmed:meshHeading | pubmed-meshheading:16781230... | lld:pubmed |
| pubmed-article:16781230 | pubmed:meshHeading | pubmed-meshheading:16781230... | lld:pubmed |
| pubmed-article:16781230 | pubmed:meshHeading | pubmed-meshheading:16781230... | lld:pubmed |
| pubmed-article:16781230 | pubmed:meshHeading | pubmed-meshheading:16781230... | lld:pubmed |
| pubmed-article:16781230 | pubmed:meshHeading | pubmed-meshheading:16781230... | lld:pubmed |
| pubmed-article:16781230 | pubmed:meshHeading | pubmed-meshheading:16781230... | lld:pubmed |
| pubmed-article:16781230 | pubmed:meshHeading | pubmed-meshheading:16781230... | lld:pubmed |
| pubmed-article:16781230 | pubmed:meshHeading | pubmed-meshheading:16781230... | lld:pubmed |
| pubmed-article:16781230 | pubmed:meshHeading | pubmed-meshheading:16781230... | lld:pubmed |
| pubmed-article:16781230 | pubmed:meshHeading | pubmed-meshheading:16781230... | lld:pubmed |
| pubmed-article:16781230 | pubmed:year | 2006 | lld:pubmed |
| pubmed-article:16781230 | pubmed:articleTitle | Abciximab and angiographic restenosis after coronary stent placement. Analysis of the angiographic substudy of ISAR-REACT--a double-blind, placebo-controlled, randomized trial evaluating abciximab in patients undergoing elective percutaneous coronary interventions after pretreatment with a high loading dose of clopidogrel. | lld:pubmed |
| pubmed-article:16781230 | pubmed:affiliation | Deutsches Herzzentrum, Munich, Germany. schuehlen@dhm.mhn.de | lld:pubmed |
| pubmed-article:16781230 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:16781230 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:16781230 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
